Bioinformatics News Feb 2008: bioinformatics, genomics, proteomics, microarray, etc.

1 2 3 4 Next

Tim Hubbard: A Bottom-Up View Of Human Genetics
The Sanger Institute was a modest and little known cluster of buildings in Cambridgeshire when genomics expert Tim Hubbard arrived in 1997. Burgeoning spending on genomic research has led to a rapid expansion—the institute now employs 800 people, more than double its size five years ago. The latest addition: a 1,000-square-meter computer center ready to crunch the mass of genomic data scientists ... (Fri, 01 Feb 2008 00:17:19 GMT)

Genomics lab can contribute to scientific advances
This week, the School of Nursing cut the ribbon for the Genomics Translational Research Laboratory, the first lab of its kind in the nation. The research conducted is an exciting development for the university, and its effects will extend far beyond the university community. (Fri, 01 Feb 2008 02:46:45 GMT)

Affymetrix Completes Acquisition Of USB Corporation
Affymetrix Inc. recently announced the completion of its acquisition of USB Corporation, a privately held Cleveland, Ohio-based company that develops, manufactures and markets an extensive line of molecular biology and biochemical reagent products. (Fri, 01 Feb 2008 06:45:27 GMT)

Current Issue:
A new grant given to the Center of Excellence for Nutritional Genomics is exposing how much is really known about vitamin D. (Fri, 01 Feb 2008 09:12:22 GMT)

Introducing a Volume That Shows How Flow Cytometry is Integrated into Modern Biotechnology
DUBLIN, Ireland----Research and Markets has announced the addition of Flow Cytometry for Biotechnology to their offering. (Fri, 01 Feb 2008 09:46:00 GMT)

Computer Science
Computer science is a subject that reaches into almost every aspect of modern life from the internet, aircraft control and ATM machines to the very latest in high-tech science, computer modelling of the brain and investigating human language. It is a subject with a big hand in defining the way we live today and where progress is a fact of life. (Fri, 01 Feb 2008 10:16:31 GMT)

Environmental Epigenetics Has Potential For Preventing And Treating Disease
New research on environmental influences on health and disease has begun to shed light on why genetically identical individuals demonstrate different characteristics, such as susceptibility to disease. Scientists have found that environmental exposure to nutritional, chemical and physical factors can alter the epigenome. (Fri, 01 Feb 2008 10:17:19 GMT)

Introducing a Volume That Shows How Flow Cytometry is Integrated into Modern Biotechnology
Research and Markets (http://www.researchandmarkets has announced the addition of Flow Cytometry for Biotechnology to their offering. (Fri, 01 Feb 2008 10:36:52 GMT)

Examine Peptidomics: The Methods and Applications
DUBLIN, Ireland----Research and Markets has announced the addition of "Peptidomics: Methods and Applications" to their offering. (Fri, 01 Feb 2008 11:00:00 GMT)

Medicine Studies
What on earth is it? Medicine Studies isn't a subject in itself: it's a catch-all term for a whole range of degrees revolving around medicine. Think medical microbiology, medical systems engineering and biomedical engineering: medicine with other stuff. (Fri, 01 Feb 2008 11:04:07 GMT)

Genetics lab to operate in Bangor temporarily
The Maine Institute for Human Genetics and Health announced Thursday that it will move into an interim laboratory facility on Sylvan Road in Bangor. (Fri, 01 Feb 2008 11:13:18 GMT)

Examine Peptidomics: The Methods and Applications
Research and Markets (http://www.researchandmarkets has announced the addition of "Peptidomics: Methods and Applications" to their offering. (Fri, 01 Feb 2008 11:43:39 GMT)

The MicroRNA 2008 Market Report Is Available Now
DUBLIN, Ireland----Research and Markets has announced the addition of "MicroRNA 2008 Market Report" to their offering. (Fri, 01 Feb 2008 11:47:00 GMT)

Distributing The Work Of Evolution Between Men And Women With The Help Of Gene Variants
Scientists from deCODE genetics (Nasdaq:DCGN) have reported the discovery of two common, single-letter variants in the sequence of the human genome (SNPs) that regulate one of the principle motors of evolution. Versions of the two SNPs, located on chromosome 4p16, have a genome-wide impact on the rate of recombination - the reshuffling of the genome that occurs in the formation of eggs and sperm. (Fri, 01 Feb 2008 13:14:48 GMT)

Minerva Biotechnologies fires CEO, files lawsuit
Nanotechnology-focused biotech firm Minerva Biotechnologies Corp. has fired its CEO and brought suit against him in Massachusetts Superior Court, according to company officials. (Fri, 01 Feb 2008 14:56:19 GMT)

Crist announces new genomics institute
Gov. Charlie Crist said Friday the state will put $80 million into the new University of Miami Human Genomics Institute. The center will focus on using human genome research preventing, detecting and treating human disease. (Fri, 01 Feb 2008 16:35:26 GMT)

UM Human Genomics Institute gets $80M
The University of Miami will receive $80 million from the state for its Human Genomics Institute, Gov. Charlie Crist announced Friday. (Fri, 01 Feb 2008 16:40:40 GMT)

UM gets $80M for genetic research
Florida Gov. Charlie Crist on Friday approved an $80 million grant to the University of Miami Miller School of Medicine for its Miami Institute for Human Genomics. (Fri, 01 Feb 2008 16:53:22 GMT)

Nanobac Pharmaceuticals Inc. Signs LOI for the Acquisition of DNAPrint Genomics
TAMPA, Fla.----Nanobac Pharmaceuticals Inc. is pleased to announce a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc. . With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods and systematic genome-based ... (Fri, 01 Feb 2008 16:55:00 GMT)

Story Ideas from the Journal of Biological Chemistry
1) Carbohydrate Regulates Stem Cell Potency; 2) Mechanism of SARS Lung Damage; 3) Structure of Important Psychiatric Enzyme Solved. (Fri, 01 Feb 2008 17:28:15 GMT)

Nanobac Pharmaceuticals Inc. Signs LOI for the Acquisition of DNAPrint Genomics
Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") is pleased to announce a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc. (OTCBB:DNAG) ("DNAPrint" or DNAP). With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying ... (Fri, 01 Feb 2008 17:37:04 GMT)

Crist announces Miami genomics institute with $80M investment
The University of Miami will open a new genome research center with state help. It's the latest step to make South Florida a hub of biomedical research. (Fri, 01 Feb 2008 18:08:00 GMT)

Identification of New Small RNAs and ORFs
The inventors have isolated a number of previously unknown sRNAs found in E. coli. Previous scientific publications by the inventors and others regarding sRNAs have shown these sRNAs to serve important regulatory roles in the cell, such as regulators of virulence and survival in host cells. (Fri, 01 Feb 2008 19:13:04 GMT)

Bay area health firms plan to join forces
Nanobac Pharmaceuticals Inc. has signed a letter of intent to acquire DNAPrint Genomics Inc. (Fri, 01 Feb 2008 20:43:09 GMT)

RNA-based methods for developmental studies are featured in Cold Spring Harbor Protocols
COLD SPRING HARBOR, N.Y. (Fri., Feb. 1, 2008) – This month’s issue of Cold Spring Harbor Protocols ( www.cshprotocols.org/TOCs/toc2 ) highlights two methods to understand developmental processes in plants and flies. (Fri, 01 Feb 2008 20:58:16 GMT)

Nanobac to Buy DNAPrint Genomics
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 01 Feb 2008 21:20:40 GMT)

Expression Patterns Of MicroRNAs Appear Altered In Colon Cancer, And Associated With Poor Outcomes
Preliminary research has found an association between certain microRNA expression patterns and poor survival and treatment outcomes for colon cancer. Colon cancer is a major cause of cancer death worldwide. Colorectal cancer is the third most common and second leading cause of cancer death in the United States. (Fri, 01 Feb 2008 23:17:53 GMT)

UM's human genomics plan on track
As it announced formal signing of the contracts to receive $80 million from the state for its Institute for Human Genomics, University of Miami leaders said they were already on the way to fulfilling their commitment to the state. (Sat, 02 Feb 2008 08:16:10 GMT)

Partnership Extends Funding For Bioscience Summer Internship
Helios Education Foundation today awarded $6.5 million to the Translational Genomics Research Institute (TGen) as part of a new partnership that extends the Helios Scholars Program at TGen for the next 25 years. The program helps cultivate new scientific and technical talent across the state of Arizona. (Sat, 02 Feb 2008 15:12:30 GMT)

Improved Prediction Of Prostrate Cancer
Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. Research published in the new online open access journal BMC Medical Genomics reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. (Sat, 02 Feb 2008 16:12:31 GMT)

iPlant Collaborative Will Unite Scientists Across Disciplines
Cold Spring Harbor Laboratory (CSHL) will play a central role in an important new initiative called the iPlant Collaborative, funded by the National Science Foundation (NSF). The Collaborative will define and address "grand challenge questions" in plant biology that have global implications. (Sat, 02 Feb 2008 17:12:30 GMT)

Dr. Vivian Cheung, Genetics Researcher At Children's Hospital, Selected As Howard Hughes Medical Institute Investigator
Vivian Cheung, M.D., a pediatric neurologist at The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, has been named a Howard Hughes Medical Institute (HHMI) investigator. Following a nationwide competition in 2007, Cheung was one of 15 physician-scientists selected recently by the prestigious research organization.Like all those chosen, Dr. (Sun, 03 Feb 2008 10:12:30 GMT)

Springer Launches new e-Product
Springer Science+Business Media has announced the release of Springer Protocols, a protocol database of more than 18,000 searchable online protocols in life sciences and biomedicine. The protocols provide step-by-step "recipes" that can be executed in a controlled laboratory environment. (Mon, 04 Feb 2008 05:09:55 GMT)

BioDiscovery Releases ImaGene 8.0 for Expression and aCGH Microarray Analysis
BioDiscovery Inc., the leading developer of integrated software solutions for microarray based research, announced today the release of ImaGene 8.0 for microarray image analysis. The new features include improved auto-gridding, faster processing for highly dense arrays, and support for multi-sample arrays. (Mon, 04 Feb 2008 07:01:00 GMT)

News From The Journal Of Biological Chemistry
Carbohydrate Regulating Stem Cell PotencyHeparan sulfate, a carbohydrate molecule that coats certain proteins on the cell surface, is critical for the proper proliferation and potency of embryonic stem cells, researchers report.Stem cells' tremendous therapeutic potential arises from their ability to continually self-renew and turn into any adult cell type. (Mon, 04 Feb 2008 12:13:31 GMT)

Lipomics Technologies to Partner With Joslin Diabetes Center in Insulin Resistance Research
Lipomics Technologies, Inc., a privately held company that specializes in clinical diagnostic development, announced today that it is engaged in a research collaboration with Joslin Diabetes Center. (Mon, 04 Feb 2008 13:00:00 GMT)

RNA-Based Methods For Developmental Studies Are Featured In Cold Spring Harbor Protocols
This month's issue of Cold Spring Harbor Protocols highlights two methods to understand developmental processes in plants and flies. Both methods involve work with RNA and are freely accessible on the Web site for Cold Spring Harbor Protocols . The first protocol describes the use of RNAi to investigate gene function in fruit flies. (Mon, 04 Feb 2008 13:13:42 GMT)

Rosetta Genomics Establishes Medical Advisory Board
Rosetta Genomics, Ltd. announced today the establishment of its Medical Advisory Board. Rosetta Genomics has assembled world-leading clinicians in the fields of oncology and women's health, to advise the company on its microRNA-based program to develop laboratory tests to best address the issues facing oncologists and pathologists today. (Mon, 04 Feb 2008 13:30:00 GMT)

Emerging Stock Report for Monday, February 04, 2008: CAAH Key Acquisitions in China!
TheSUBWAY.com announces the following stocks to its Action List: China America Holdings, Inc., DNAPrint Genomics, Inc., Paradigm Medical Industries, Inc., Apple. (Mon, 04 Feb 2008 14:19:00 GMT)

GenomeQuest, Inc. Launches ''DrugBank Pro'' Database, With Six-Month Advance DrugBank Data and Exclusive IND Information
WESTBOROUGH, Mass.----GenomeQuest, Inc., the leader in genomic search, today announced the launch of "DrugBank Pro", an exclusive database of sequence and annotation information on all approved drugs, their targets and metabolizing enzymes located in the University of Alberta's DrugBank database, six months prior to publication, along with full access to its non-public Investigational New Drug ... (Mon, 04 Feb 2008 15:00:00 GMT)

GenomeQuest, Inc. Launches ''DrugBank Pro'' Database, With Six-Month Advance DrugBank Data and Exclusive IND Information
GenomeQuest, Inc., the leader in genomic search, today announced the launch of "DrugBank Pro", an exclusive database of sequence and annotation information on all approved drugs, their targets and metabolizing enzymes located in the University of Alberta's DrugBank database, six months prior to publication, along with full access to its non-public Investigational New Drug (IND) database of drugs ... (Mon, 04 Feb 2008 15:44:20 GMT)

Luminex Corporation to Webcast Investor Presentation
Luminex Corporation (9295;NASDAQ:LMNX) today announced that its senior management will host an investor (Mon, 04 Feb 2008 16:04:51 GMT)

Luminex Corporation to Webcast Investor Presentation
Luminex Corporation (NASDAQ:LMNX) today announced that its senior management will host an investor meeting on Thursday, March 6, 2008, at the Grand Hyatt in New York City. Luminex management will review the Company's financial progress, operating highlights, strategic initiatives and provide an update on product development activities followed by a question and answer session. (Mon, 04 Feb 2008 16:44:39 GMT)

Toward An Effective Treatment For Monkeypox
Researchers report an advance toward developing much-needed new drugs and vaccines for monkeypox. The disease occurs mainly among rodents, monkeys, and other animals in Africa, but has been transmitted to humans resulting in high mortality rates. Although this deadly viral disease rarely occurs naturally in the United States, it is a potential bioterrorism agent. ... (Mon, 04 Feb 2008 17:06:58 GMT)

Improved Prediction Of Prostrate Cancer Outcome With New Model
Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. A new model may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have ... (Mon, 04 Feb 2008 17:07:42 GMT)

Illumina Reports Financial Results for Fourth Quarter and Fiscal 2007
Illumina, Inc. (7884;NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal (Mon, 04 Feb 2008 21:19:12 GMT)

Florida Pumps $80M into Miami Human Genomics Institute
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 04 Feb 2008 21:20:40 GMT)

Illumina Reports Financial Results for Fourth Quarter and Fiscal 2007
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal 2007. (Mon, 04 Feb 2008 21:43:25 GMT)

Project Aims to Map DNA of 1,000 People
WASHINGTON -- Any two people may be roughly 99 percent identical at the genetic level. But the small differences are what tantalize scientists, and now they plan to map the DNA of 1,000 people worldwide to examine human genetic variation. (Mon, 04 Feb 2008 22:17:56 GMT)

GenomeQuest, Inc. Launches 'DrugBank Pro' Database, With Six-Month Advance DrugBank Data And Exclusive IND Information
GenomeQuest, Inc., the leader in genomic search, recently announced the launch of "DrugBank Pro", an exclusive database of sequence and annotation information on all approved drugs, their targets and metabolizing enzymes located in the University of Alberta's DrugBank database, six months prior to publication, along with full access to its non-public Investigational New Drug (IND) database of ... (Tue, 05 Feb 2008 05:10:02 GMT)

Team led by Indian compiles online protein encyclopaedia
An international team led by an Indian biologist has pioneered an online encyclopaedia of human proteins that will help accelerate biomedical research and drug discovery. (Tue, 05 Feb 2008 07:24:54 GMT)

Mane event: Recombination in lion feline immunodeficiency virus
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics. The sequencing of the two full FIV genomes of different lion subtypes shows the importance of whole-genome analysis in understanding complex genetic events. These findings will be relevant to big cat ... (Tue, 05 Feb 2008 10:43:32 GMT)

Today's Research: Tomorrow's Health: Experimental Biology April 5-9 2008
More than 13,000 biological and biomedical scientists will gather for the Experimental Biology 2008 meeting in San Diego April 5-9.The theme of the annual meeting, now in its 18th year, is "Today's Research: Tomorrow's Health." Thousands of lectures, symposia, research presentations and exhibits have been selected because of their potential to shape future and current clinical advances. (Tue, 05 Feb 2008 11:12:41 GMT)

Recombination In Lion Feline Immunodeficiency Virus
Parts of feline immunodeficiency virus (FIV) isolated from wild lions have undergone substantial genetic recombination, says research published in the online open access journal BMC Genomics. The sequencing of the two full FIV genomes of different lion subtypes shows the importance of whole-genome analysis in understanding complex genetic events. (Tue, 05 Feb 2008 11:14:01 GMT)

Cell Signaling Technology Announces Continued PhosphoScan(R) Proteomics Research Project with Bristol-Myers Squibb for ...
DANVERS, Mass.----Cell Signaling Technology, Inc. announced today the continuation of a research agreement with Bristol-Myers Squibb Company under which CST will employ its patented PhosphoScan® technology in the cell and tumor phospho-profiling of a Bristol-Myers Squibb small-molecule kinase inhibitor. (Tue, 05 Feb 2008 12:00:00 GMT)

Reverse Engineering Biological Networks Attempts a Systematic Evaluation of Reverse Engineering Methods
DUBLIN, Ireland----Research and Markets has announced the addition of "Reverse Engineering Biological Networks" to their offering. (Tue, 05 Feb 2008 12:18:00 GMT)

GSK Extends GeneGo License and Adds New Products
GeneGo, Inc., the leading systems biology tools company, announced today that GSK has extended their licensing agreement with GeneGo and have added additional capability. (Tue, 05 Feb 2008 13:00:00 GMT)

SGI to integrate eXludus software into cluster offering
eXludus Technologies, the leading developer of multi-core system capacity management, virtualization and provisioning solutions, today announced a reseller relationship with SGI , a leader in high-performance computing. (Tue, 05 Feb 2008 13:00:00 GMT)

Strategic Diagnostics to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference February 20
Strategic Diagnostics Inc. (Nasdaq:SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, environmental and life science applications, announced today that its President and Chief Executive Officer, Matthew Knight, and the Company's Chief Financial Officer, Stan Fronczkowski, will present at Roth Capital Partners' 20th Annual Growth ... (Tue, 05 Feb 2008 13:00:01 GMT)

The Handbook of Tuberculosis: Molecular Biology and Biochemistry is an Essential Resource to Molecular and Cell ...
Research and Markets (http://www.researchandmarkets has announced the addition of Handbook of Tuberculosis: Molecular Biology and Biochemistry to their offering. (Tue, 05 Feb 2008 13:08:36 GMT)

News From The American Chemical Society
Iodized table salt may be low in iodine, raising health concernsAmid concern that people in the United States are consuming inadequate amounts of iodine, scientists in Texas have found that 53 percent of iodized salt samples contained less than the U.S. Food and Drug Administration (FDA) recommended level of this key nutrient. (Tue, 05 Feb 2008 13:14:01 GMT)

4th Biomarker Workshop at the NMI in Reutlingen: Another success
The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130, this year's workshop exceeded all previous ones. (Tue, 05 Feb 2008 13:32:21 GMT)

Comparative Genomics Reveals Differences in Lion FIV Strains
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 05 Feb 2008 15:50:20 GMT)

Disrupted genetic regulation causes common disturbance in metabolism of fat
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks. Uppsala University scientists have now developed a pioneering method and can show for the first time what genes are regulated by the gene USF1, which is known to cause the disease. These findings are being presented today in the leading journal Genome Research. (Tue, 05 Feb 2008 15:58:32 GMT)

SGI to Integrate eXludus
MONTREAL -- eXludus Technologies, the leading developer of multi-core system capacity management, virtualization and provisioning solutions, today announced a reseller relationship with SGI (NASDAQ: SGIC - message board ), a leader in high-performance computing. (Tue, 05 Feb 2008 16:07:24 GMT)

Small caps round-up: Proteome, MKM, Plethora, Toluna, Twenty
Applied proteomics firm Proteome Sciences said it is not aware of any reason behind its recent share price increase. (Tue, 05 Feb 2008 16:56:00 GMT)

SGI to Intergrate eXludus Software Into Cluster Offering
eXludus, a developer of multi-core system capacity management, virtualization and provisioning solutions, announced a reseller relationship with SGI. SGI will embed eXludus Grid Optimizer software in its new BioCluster solution, developed specifically for the life sciences market. (Tue, 05 Feb 2008 17:14:10 GMT)

Invitrogen, Agilent Technologies Settle Multiple Patent Litigations
CARLSBAD, Calif., & SANTA CLARA, Calif.----Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. (Tue, 05 Feb 2008 21:08:00 GMT)

Invitrogen Announces Fourth Quarter and Full Year 2007 Results
Invitrogen Corporation (Nasdaq:IVGN) today announced results for its fourth quarter and full year ended December 31, 2007. Revenues for the fourth quarter were $336 million, resulting in full year sales of $1,282 million, an increase ... (Tue, 05 Feb 2008 21:10:55 GMT)

Researchers identify a worldwide-distributed clone of bacteria responsible for Legionnaire's disease
Wednesday, February 6, 2008 – A study published online today in Genome Research ( www.genome.org ) describes new insights into Legionella pneumophila , the bacteria responsible for most cases of Legionnaires’ disease. (Tue, 05 Feb 2008 22:09:10 GMT)

Invitrogen, Agilent Technologies Settle Multiple Patent Litigations
Invitrogen Corporation and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen and Stratagene, Inc. Agilent acquired Stratagene in 2007. (Tue, 05 Feb 2008 22:15:36 GMT)

$20 million Arizona venture fund dedicated to biosciences
A consortium of biotechnology and investment professionals have partnered to create Arizona's first venture capital firm dedicated to early-stage bioscience companies. (Wed, 06 Feb 2008 01:10:33 GMT)

Researchers Identify A Worldwide-distributed Clone Of Bacteria Responsible For Legionnaire's Disease
A study published online today in Genome Research describes new insights into Legionella pneumophila, the bacteria responsible for most cases of Legionnaires' disease. This report investigates the genetic background of L. pneumophila, provides clues to the evolution and emergence of this pathogen, and describes the identification of a worldwide-distributed epidemic clone. (Wed, 06 Feb 2008 02:13:01 GMT)

$20 million fund will boost bioscience companies
Arizona technology and business leaders have established a $20 million venture-capital fund that will target early-stage bioscience companies seeking a financial boost to develop their ideas. (Wed, 06 Feb 2008 04:10:08 GMT)

Bioengineering Bugs to Make Fuel
Maverick scientist Craig Venter announces that his team has created the largest manmade molecule in history—a chromosome that may be the key to building organisms that can make fuel, and much more. (Wed, 06 Feb 2008 06:00:00 GMT)

Life Sciences IT Vendors Enjoy Exciting Growth Potential in Europe
Life sciences companies across Europe are looking for an extensive mix of services and solutions. Accordingly, service opportunities in life sciences IT (LSIT) are set to expand considerably as life sciences gear up to tackle bioinformatics and a host of key technology solutions. (Wed, 06 Feb 2008 10:28:57 GMT)

Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help Improve Proteomics Research
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, today announced an expansion of its line of labeling chemistry reagents used for proteomics research in academic and biopharmaceutical laboratories. (Wed, 06 Feb 2008 12:00:00 GMT)

Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help Improve Proteomics Research
Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced an expansion of its line of labeling chemistry reagents used for proteomics research in academic and biopharmaceutical laboratories. The new 8plex version of Applied Biosystems' iTRAQ(R) reagents is designed to double the existing capacity for discovering proteins and comparing protein levels between biological ... (Wed, 06 Feb 2008 12:31:38 GMT)

Znomics Advances Drug Discovery Efforts in Zebrafish With Launch of New Human Disease Library
PORTLAND, Ore., Feb. 6, 2008 -- Znomics, Inc. , a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, today announced it has achieved mutations in 193 key genes, representing nearly 50 percent of the known "druggable" disease genes. (Wed, 06 Feb 2008 13:00:00 GMT)

Common Disturbance In Metabolism Of Fat Caused By Disrupted Genetic Regulation
The disease familial combined hyperlipidemia (FCH) is a common cause of disturbed metabolism of fat and early heart attacks. Uppsala University scientists have now developed a pioneering method and can show for the first time what genes are regulated by the gene USF1, which is known to cause the disease. These findings are being presented today in the leading journal Genome Research. (Wed, 06 Feb 2008 13:15:14 GMT)

Journal Of Cardiovascular Translational Research Will Bridge Gap Between Biomedical Research And Clinical Medicine
Springer and the International Society for Cardiovascular Translational Research (ISCTR) are founding a new, quarterly biomedical publication called the Journal of Cardiovascular Translational Research (JCTR). (Wed, 06 Feb 2008 13:15:53 GMT)

U of T gets $23.3M in tech funding
The University of Toronto will get $23.3 million in provincial funding for four new technology projects, including to prevent infectious diseases using nanotechnology and to place wireless internet services in rural communities, the government said Tuesday. (Wed, 06 Feb 2008 16:09:05 GMT)

Plant DNA 'barcode' boosts biodiversity research
Researchers have found a section of plant DNA that could be used as the universal 'barcode' to identify flowering plants, aiding biodiversity research. (Wed, 06 Feb 2008 18:05:16 GMT)

InforSense and BioWisdom to Integrate Analytic Technologies for Bioinformatics
InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that it will integrate BioWisdom's SRS bioinformatics software with InforSense's workflow analytics platform, enabling customers to automate and improve their bioinformatics analysis. (Wed, 06 Feb 2008 20:19:00 GMT)

Illumina Sequences the First African Human Genome
SAN DIEGO----Illumina, Inc. today announced that scientists at the Company have sequenced the genome of an anonymous African male , using the Genome Analyzer. Sequencing of this HapMap sample was conducted internally and marks the first human genome sequence generated exclusively with paired reads of 35 to 50 bases in length. (Wed, 06 Feb 2008 21:01:00 GMT)

Illumina Sequences the First African Human Genome
Illumina, Inc. (7884;NASDAQ:ILMN) today announced that scientists at the Company have sequenced the genome (Wed, 06 Feb 2008 21:17:20 GMT)

Genetic-mapping unveiled to test infectious diseases
A team of scientists unveiled a new playbook Wednesday in the fight against infectious disease outbreaks: Genetic-mapping by computers to find bugs that slip past all other modern medical tests. (Wed, 06 Feb 2008 22:41:04 GMT)

Global Heart Experts Gather in San Diego February 9th--10th
More than thirty international experts from all fields of cardiovascular research will gather in San Diego on February 9 and 10, 2008 to share the latest advances in the fields of cellular therapy and genomics in the treatment of cardiovascular disease. (Wed, 06 Feb 2008 23:19:08 GMT)

Scientists confirm new virus responsible for deaths of transplant recipients in Australia
In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Control and 454 Life Sciences link the discovery of a new arenavirus to the deaths of three ... (Wed, 06 Feb 2008 23:43:41 GMT)

New technology adds value to dairy
Scientists are creating new economic opportunities in our dairy industry, Pete Hodgson, Minister of Research Science and Technology said during a visit to AgResearch campus near Hamilton today. (Thu, 07 Feb 2008 02:54:39 GMT)

State funds non-SUS schools despite budget cuts
Some University administrators and local politicians are upset with Gov. Charlie Crist's decision to grant $140 million to one private university and another out-of-state university. (Thu, 07 Feb 2008 06:03:04 GMT)

GSK extends licensing agreement with GeneGo
GlaxoSmithKline has extended its licensing agreement with GeneGo and has added additional capability. This agreement will provide GlaxoSmithKline researchers in bioinformatics, R&D and clinical studies with global access to MetaCore, MapEditor and MetaBase. (Thu, 07 Feb 2008 11:06:00 GMT)

Powerful Tool For Pathogen Discovery Enables Improvements In Screening For Transplant Safety
In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Con (Thu, 07 Feb 2008 12:13:31 GMT)

Applied Biosystems' Software Development Community Helps Scientists Address Next-Generation Sequencing Bioinformatics ...
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, today announced that its Software Development Community has established relationships resulting in two formal agreements intended to help scientists address next-generation sequencing bioinformatics challenges. (Thu, 07 Feb 2008 12:30:00 GMT)

Calibrant Announces Ovarian and Breast Cancer Drug Discovery Partnership with Yale University
GAITHERSBURG, Md.----Calibrant Biosystems today announced a research collaboration with the Yale University School of Medicine to identify novel ovarian and breast cancer drug targets from clinical tissue specimens using Calibrant's Gemini proteomics platform. (Thu, 07 Feb 2008 13:00:00 GMT)

TeleChem International, Inc. Completes Business Combination With Integrated Media Holdings, Inc.
Integrated Media Holdings, Inc. today announced that it has completed the definitive agreement for a business combination via an acquisition of all outstanding common stock of TeleChem International, Inc., a pioneer in the biotech market located in Sunnyvale, California. (Thu, 07 Feb 2008 13:00:00 GMT)

Marshfield Clinic Research Team Uses Affymetrix DMET Solution to Discover Genetic Variant Affecting Warfarin ...
SANTA CLARA, Calif. & MARSHFIELD, Wis.----Affymetrix Inc. and Marshfield Clinic today announced that researchers at Marshfield Clinic used the Affymetrix Drug Metabolizing Enzymes and Transporters solution to discover a genetic variation associated with an individual's response to the drug warfarin. (Thu, 07 Feb 2008 13:00:00 GMT)

Genizon BioSciences Collaborating with London Genetics to Enhance Gene Discovery Findings in Schizophrenia
MONTREAL----Genizon BioSciences Inc. and London Genetics Ltd today announced an agreement under which they will collaborate to replicate discoveries made by Genizon in a genome-wide association study of schizophrenia. (Thu, 07 Feb 2008 13:00:00 GMT)

AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
CARLSBAD, Calif., Jan. 24 - AutoGenomics, a leader in developing automated molecular testing solutions announced today that it has obtained clearance from the Food and Drug Administration (FDA) for its INFINITI 2C9-VKORC1 Multiplex Assay for Warfarin. The company has already received FDA clearance for its INFINITI Analyzer and FII/FV assays in 2007. "We are excited to receive FDA clearance for ... (Thu, 07 Feb 2008 14:15:13 GMT)

University growing through collection of grants, federal funds
The Miami Institute for Human Genomics was awarded the Innovation Incentive Fund award, an $80 million grant, by Florida Gov. Charlie Crist this past weekend. Analyses show that the Innovation Incentive Fund award would help create about 300 new jobs in the University of Miami community. (Thu, 07 Feb 2008 14:55:01 GMT)

Applied Biosystems' Software Development Community Helps Scientists Address Next-Generation Sequencing Bioinformatics ...
Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that its Software Development Community has established relationships resulting in two formal agreements intended to help scientists address next-generation sequencing bioinformatics challenges. Geospiza(R) and GenomeQuest will develop bioinformatics tools that are expected to advance data analysis and management for ... (Thu, 07 Feb 2008 15:23:34 GMT)

Applied Biosystems' Software Development Community Helps Scientists Address Next-Generation Sequencing Bioinformatics ...
Applied Biosystems, an Applera Corporation business, announced that its Software Development Community has established relationships resulting in two formal agreements intended to help scientists address next-generation sequencing bioinformatics challenges (Thu, 07 Feb 2008 15:40:19 GMT)

ABI Partners with Geospiza, GenomeQuest to Build Bioinformatics Platform for Next-Gen Sequencing
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 07 Feb 2008 15:53:33 GMT)

$3.7 Million to Expand Yale Study of How Plant Proteins Function
The National Science Foundation (NSF) awarded $3.7 million to researchers in the Yale Center for Genomics and Proteomics (YCGP) for work that will triple the number of plant proteins whose biochemical functions can be studied in protein microarrays. (Thu, 07 Feb 2008 17:11:04 GMT)

X PRIZE Foundation Announces Official Contenders in Private Moon Race
The X PRIZE Foundation will announce the first group of teams registered to compete for the $30 million Google Lunar X PRIZE on Thursday, Feb. 21 at Google Headquarters in Mountain View, CA. A new preferred partner will also be announced. (Thu, 07 Feb 2008 17:39:06 GMT)

New Delhi, India February 7, 2008
Backed by the government, the industry logs Rs 926 cr sales in 2006-07. The agri-biotech sector in India is growing at 30 per cent for the last five years, and it is likely to maintain the growth in the future as well, says a Rabobank report titled “Indian agri-biotech sector: Emerging scenario, issues and challenges”. (Thu, 07 Feb 2008 17:40:29 GMT)

BioInformatics, LLC Investigates Trends in Advertising to Life Scientists
ARLINGTON, Va.----BioInformatics, LLC -the leading market research and consulting firm serving the life science industry-announces the publication of its latest report, "Advertising to Life Scientists: Resolving the Print vs. (Thu, 07 Feb 2008 17:48:00 GMT)

BioInformatics, LLC Investigates Trends in Advertising to Life Scientists
BioInformatics, LLC ( http://www.gene2drug.com )-the leading market research and consulting firm serving the life science industry-announces the publication of its latest report, "Advertising to Life Scientists: Resolving the Print vs. Online Dilemma." The report is designed to assist companies advertising in the life science market in understanding how scientists use and react to advertising ... (Thu, 07 Feb 2008 17:55:51 GMT)

Local News New management team will take Genesis Genomics, global
Genesis Genomics has a new management team. Bob Poulter is assuming the position of CEO saying ''its time for the company to go public'' and is repositioning itself to compete on a global market. (Thu, 07 Feb 2008 18:39:12 GMT)

Researchers decode genetics of rare photosynthetic bacteria
TEMPE, Ariz. – A bacterium that harvests far-red light by making a rare form of chlorophyll (chlorophyll d) has revealed its genetic secrets, according to a team of researchers who recently sequenced the bacteria’s genome. (Thu, 07 Feb 2008 18:52:05 GMT)

Johns Hopkins researcher leads international effort to create 'proteinpedia'
A researcher at the Johns Hopkins Institute of Genetic Medicine has led the effort to compile to date the largest free resource of experimental information about human proteins. Reporting in the February issue of Nature Biotechnology, the research team describes how all researchers around the world can access this data and speed their own research. (Thu, 07 Feb 2008 19:09:57 GMT)

BioInformatics, LLC Investigates Trends in Advertising to Life Scientists
BioInformatics, LLC (http://www.gene2drug.com)-the leading market research and consulting firm serving the life science industry-announces the publication of its latest report, "Advertising to Life Scientists: Resolving the Print vs. Online Dilemma." The report is designed to assist companies advertising in the life science market in understanding how scientists use and react to advertising in ... (Thu, 07 Feb 2008 19:46:03 GMT)

Promega GloMax(R) Luminometer´s Multi-Mode Capability Enhances Lab Performance
Promega Corporation announces the release of the GloMax(R)-Multi Detection System. The new GloMax (Thu, 07 Feb 2008 20:14:38 GMT)

Story ideas from the Journal of Lipid Research
Treatment with the antibiotic myriocin can halt the growth of established arterial plaques in mice, researchers report. Myriocin kills bacteria by disrupting the formation sphingomyelin, a fatty molecule that is a key part of their cell membranes. (Thu, 07 Feb 2008 20:39:57 GMT)

Luminex Corporation Reports Fourth Quarter and Year-End 2007 Results
Luminex Corporation (9295;NASDAQ:LMNX) today announced financial results for the fourth quarter and year (Thu, 07 Feb 2008 21:14:39 GMT)

UM wants $385M in bonds for hospital
The University of Miami wants Miami-Dade County to issue tax-exempt revenue bonds of up to $385 million to support its hospital and medical campus. (Thu, 07 Feb 2008 23:19:34 GMT)

New insights into Legionella pneumophila
A study published online in Genome Research (www.genome.org) describes new insights into Legionella pneumophila, the bacteria responsible for most cases of Legionnaires' disease. (Fri, 08 Feb 2008 02:54:54 GMT)

InforSense and BioWisdom sign bioinformatics agreement
InforSense has said that it will integrate BioWisdoms SRS bioinformatics software with its workflow analytics platform, enabling customers to automate and improve their bioinformatics analysis. (Fri, 08 Feb 2008 11:11:05 GMT)

3.7 Million Dollars To Expand Yale Study Of How Plant Proteins Function
The National Science Foundation (NSF) awarded 3.7 million dollars to researchers in the Yale Center for Genomics and Proteomics (YCGP) for work that will triple the number of plant proteins whose biochemical functions can be studied in protein microarrays. The YCGP, launched in 2002, promotes cutting-edge research in the area of genomics and proteomics. (Fri, 08 Feb 2008 11:15:53 GMT)

Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share ...
Beckman Coulter, Inc. , a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today fourth quarter and year ended December 31, 2007 results. (Fri, 08 Feb 2008 12:00:00 GMT)

Tomato Pathogen Genome May Offer Clues About Bacterial Evolution At Dawn Of Agriculture
The availability of new genome sequencing technology has prompted a Virginia Tech plant scientist to test an intriguing hypothesis about how agriculture's early beginnings may have impacted the evolution of plant pathogens. (Fri, 08 Feb 2008 12:16:23 GMT)

Luminex Corporation to Host the Planet xMAP USA 2008 Multiplexing Symposium in Boston
AUSTIN, Texas----Luminex Corporation , the worldwide leader in multiplexed solutions, today announced that it will host Planet xMAP USA 2008, the annual North American multiplexing technology symposium, March 3-5, at the Park Plaza Hotel in Boston, Massachusetts. (Fri, 08 Feb 2008 14:00:00 GMT)

Luminex Corporation to Host the Planet xMAP USA 2008 Multiplexing Symposium in Boston
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it will host Planet xMAP USA 2008, the annual North American multiplexing technology symposium, March 3-5, at the Park Plaza Hotel in Boston, Massachusetts. This fifth annual symposium will bring together leading scientists performing groundbreaking work on the Luminex xMAP(R) multiplexing ... (Fri, 08 Feb 2008 14:16:12 GMT)

Chemical Chaperone Could Open Door To Treatment Of Neurological Disorder
An unexpected finding turned out to be a clue leading researchers to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder. They believe the approach also could be useful for more common diseases -- such as cystic fibrosis -- that stem from a similar type of defect. (Fri, 08 Feb 2008 14:24:33 GMT)

GM Canola Ban "Disappointing"
The South Australian Government's decision to extend a moratorium on genetically modified canola is not supported by scientific evidence and may send the wrong message about the role of science in agriculture, experts in plant science and technology say. (Fri, 08 Feb 2008 14:32:00 GMT)

Company claims to have sequenced man's genome cheaply
Critics question accuracy and US$100,000 price tag. (Fri, 08 Feb 2008 19:09:38 GMT)

Race is on to produce a personal - and cheap - genome readout
If the cost of sequencing a human genome can drop, it would start to become feasible to tell what diseases people might be at risk for. (Fri, 08 Feb 2008 19:29:07 GMT)

TRADE NEWS: Agilent Technologies Announces Efforts to Streamline High-Throughput Sequencing
Agilent Technologies Inc. (NYSE:A) today announced that findings stemming from the use of a novel method to further increase the value of high-throughput DNA sequencing were presented at the Advances in Genome and Biology Technology ... (Fri, 08 Feb 2008 20:15:42 GMT)

Ontario Institute Launches Genomics Sector Innovation Network
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 08 Feb 2008 20:28:23 GMT)

Please sequence my eel
Researchers campaign to get the electric fish genome sequenced. (Fri, 08 Feb 2008 22:24:38 GMT)

Drug giant seals deal
Roche has secured a majority of shares for Tucson's Ventana Medical Systems, paving the road for one of the world's largest pharmaceutical-industry companies in Arizona. (Fri, 08 Feb 2008 22:56:48 GMT)

The Race to Read Genomes on a Shoestring, Relatively Speaking
If the cost of sequencing a human genome can drop to $1,000 or below, experts say it would start to become feasible to tell what diseases people might be at risk for. (Sat, 09 Feb 2008 03:18:43 GMT)

Doc launches 'proteinpedia'
Akhilesh Pandey has created an online encyclopaedia of human proteins that will help biomedical research and drug discovery. (Sat, 09 Feb 2008 21:35:55 GMT)

International Effort To Create 'Proteinpedia' For Scientists Underway
A researcher at the Johns Hopkins Institute of Genetic Medicine has led the effort to compile to date the largest free resource of experimental information about human proteins. The research team describes how all researchers around the world can access this data and speed their own research. (Sun, 10 Feb 2008 04:23:21 GMT)

Lion Feline Immunodeficiency Virus Has Undergone Substantial Genetic Recombination
Parts of feline immunodeficiency virus isolated from wild lions have undergone substantial genetic recombination. The sequencing of the two full FIV genomes of different lion subtypes shows the importance of whole-genome analysis in understanding complex genetic events. These findings will be relevant to big cat conservation and developing more effective animal models for HIV. ... (Sun, 10 Feb 2008 04:23:41 GMT)

Life sciences bloom as VC funding rises
Investors find balance | Chart: Q4 funding Within Silicon Valley, the life sciences sector is often overshadowed by flashy Internet brands and global tech giants, but for venture capitalists, it may hold the greatest long-term potential. (Sun, 10 Feb 2008 11:55:41 GMT)

Unique Medical School Partnership Established By Maine Medical Center/Tufts University School Of Medicine
Tufts University School of Medicine and Maine Medical Center have announced the establishment of a new partnership with a "uniquely Maine" curriculum.Medical students will spend their first two years at Tufts, then move to Maine Medical Center for the entire clerkship period in year three and portions of the monthly rotations in year four. (Sun, 10 Feb 2008 12:14:32 GMT)

News From The Journal Of Lipid Research
Setting up a roadblock for atherosclerosisTreatment with the antibiotic myriocin can halt the growth of established arterial plaques in mice, researchers report.Myriocin kills bacteria by disrupting the formation sphingomyelin, a fatty molecule that is a key part of their cell membranes. (Sun, 10 Feb 2008 16:14:33 GMT)

BioScience Law Review
Practical information for lawyers advising bio-science and bio-technology enterprises: The rapid advances in bio-science and bio-technology have resulted in a wealth of dynamic new industries and promise great advances in medical therapies and related benefits. (Sun, 10 Feb 2008 19:08:59 GMT)

'Proteinpedia' Online Human Protein Encyclopedia Will Speed Research
A researcher at the Johns Hopkins Institute of Genetic Medicine has led the effort to compile to date the largest free resource of experimental information about human proteins. Reporting in the February issue of Nature Biotechnology, the research team describes how all researchers around the world can access this data and speed their own research. (Sun, 10 Feb 2008 20:14:32 GMT)

1 2 3 4 Next